Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Pathogens ; 10(8)2021 Aug 21.
Article in English | MEDLINE | ID: mdl-34451526

ABSTRACT

Human cytomegalovirus infection of the developing fetus is a leading cause of neurodevelopmental disorders in infants and children, leading to long-term neurological sequela in a significant number of infected children. Current understanding of the neuropathogenesis of this intrauterine infection is limited because of the complexity of this infection, which includes maternal immunological responses that are overlaid on virus replication in the CNS during neurodevelopment. Furthermore, available data from human cases are observational, and tissues from autopsy studies have been derived from only the most severe infections. Animal models of this human infection are also limited by the strict species specificity of cytomegaloviruses. However, informative models including non-human primates and small animal models have been developed. These include several different murine models of congenital HCMV infection for the study of CMV neuropathogenesis. Although individual murine models do not completely recapitulate all aspects of the human infection, each model has provided significant information that has extended current understanding of the neuropathogenesis of this human infection. This review will compare and contrast different murine models in the context of available information from human studies of CNS disease following congenital HCMV infections.

2.
J Neurosci ; 36(4): 1324-35, 2016 Jan 27.
Article in English | MEDLINE | ID: mdl-26818519

ABSTRACT

Aberrant gene expression within the hippocampus has recently been implicated in the pathogenesis of obesity-induced memory impairment. Whether a dysregulation of epigenetic modifications mediates this disruption in gene transcription has yet to be established. Here we report evidence of obesity-induced alterations in DNA methylation of memory-associated genes, including Sirtuin 1 (Sirt1), within the hippocampus, and thus offer a novel mechanism by which SIRT1 expression within the hippocampus is suppressed during obesity. Forebrain neuron-specific Sirt1 knock-out closely recapitulated the memory deficits exhibited by obese mice, consistent with the hypothesis that the high-fat diet-mediated reduction of hippocampal SIRT1 could be responsible for obesity-linked memory impairment. Obese mice fed a diet supplemented with the SIRT1-activating molecule resveratrol exhibited increased hippocampal SIRT1 activity and preserved hippocampus-dependent memory, further strengthening this conclusion. Thus, our findings suggest that the memory-impairing effects of diet-induced obesity may potentially be mediated by neuroepigenetic dysregulation of SIRT1 within the hippocampus. SIGNIFICANCE STATEMENT: Previous studies have implicated transcriptional dysregulation within the hippocampus as being a relevant pathological concomitant of obesity-induced memory impairment, yet a deeper understanding of the basis for, and etiological significance of, transcriptional dysregulation in this context is lacking. Here we present the first evidence of epigenetic dysregulation (i.e., altered DNA methylation and hydroxymethylation) of memory-related genes, including Sirt1, within the hippocampus of obese mice. Furthermore, experiments using transgenic and pharmacological approaches strongly implicate reduced hippocampal SIRT1 as being a principal pathogenic mediator of obesity-induced memory impairment. This paper offers a novel working model that may serve as a conceptual basis for the development of therapeutic interventions for obesity-induced memory impairment.


Subject(s)
Hippocampus/metabolism , Memory Disorders/etiology , Neurons/metabolism , Obesity/complications , Obesity/physiopathology , Sirtuin 1/metabolism , Animals , Antioxidants/pharmacology , DNA Methylation/drug effects , DNA Methylation/genetics , Diet, High-Fat/adverse effects , Dietary Supplements , Disease Models, Animal , Excitatory Postsynaptic Potentials/drug effects , Excitatory Postsynaptic Potentials/genetics , Exploratory Behavior/drug effects , Exploratory Behavior/physiology , Gene Expression Regulation/drug effects , Gene Expression Regulation/genetics , Insulin/metabolism , Male , Memory Disorders/diet therapy , Memory Disorders/physiopathology , Mice , Mice, Inbred C57BL , Mice, Transgenic , Obesity/chemically induced , Prosencephalon/pathology , Recognition, Psychology/drug effects , Recognition, Psychology/physiology , Resveratrol , Sirtuin 1/genetics , Spatial Memory/drug effects , Spatial Memory/radiation effects , Stilbenes/pharmacology , Time Factors
3.
Nat Neurosci ; 16(10): 1445-52, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23974711

ABSTRACT

Reward-related memories are essential for adaptive behavior and evolutionary fitness, but they are also a core component of maladaptive brain diseases such as addiction. Reward learning requires dopamine neurons located in the ventral tegmental area (VTA), which encode relationships between predictive cues and future rewards. Recent evidence suggests that epigenetic mechanisms, including DNA methylation, are essential regulators of neuronal plasticity and experience-driven behavioral change. However, the role of epigenetic mechanisms in reward learning is poorly understood. Here we show that the formation of reward-related associative memories in rats upregulates key plasticity genes in the VTA, which are correlated with memory strength and associated with gene-specific changes in DNA methylation. Moreover, DNA methylation in the VTA is required for the formation of stimulus-reward associations. These results provide the first evidence that that activity-dependent methylation and demethylation of DNA is an essential substrate for the behavioral and neuronal plasticity driven by reward-related experiences.


Subject(s)
Association Learning/physiology , Conditioning, Psychological/physiology , DNA Methylation/genetics , Reward , Animals , Cells, Cultured , Dopaminergic Neurons/metabolism , Male , Random Allocation , Rats , Rats, Sprague-Dawley
4.
Eur J Endocrinol ; 152(3): 479-83, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15757866

ABSTRACT

Variation between the sexes in cardiac function have been established. The extent to which sex hormones are responsible for these differences is unclear. The current study was designed to determine whether testosterone acts acutely to enhance contractility of cultured rat ventricular myocytes. Following a 24-h treatment with testosterone (1 microM), isolated rat ventricular myocytes display a 21% increase (P < 0.01) in peak shortening and an 18% decrease (P < 0.02) in time to peak shortening. In accordance with this change, testosterone treatment produced an 18% decline (P < 0.002) in the time to relengthening when compared to vehicle-treated controls. These results provide the first evidence that short-term androgen exposure acts directly to stimulate contractility of isolated rat ventricular myocytes and thus may play a role in regulating cardiac performance in males and thereby contribute to sex differences in cardiac function.


Subject(s)
Myocardial Contraction/drug effects , Myocytes, Cardiac/physiology , Testosterone/pharmacology , Ventricular Function/drug effects , Animals , Cell Separation , Cells, Cultured , Male , Myocytes, Cardiac/drug effects , Myocytes, Cardiac/metabolism , Rats , Rats, Sprague-Dawley , Receptors, Androgen/metabolism , Testosterone Propionate/pharmacology , Time Factors
5.
Endocrine ; 24(2): 137-40, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15347839

ABSTRACT

Sex differences in cardiac function have been identified. Studies suggest that the presence of testosterone in males may contribute to the observed differences in cardiac function. Our laboratory has shown previously that testosterone treatment of gonadectomized adult male rats enhances contractility of isolated rat ventricular myocytes. In this study we tested the hypothesis that gonadectomy and hormone replacement influences contractility by altering myosin heavy chain (MHC) composition. To test this hypothesis we analyzed myosin isoform expression in ventricular myocytes isolated from castrated rats displaying a decrease in myocyte contractile velocity and compared them to castrates treated with testosterone that displayed normal myocyte shortening velocity. Sixteen weeks after castration isolated rat ventricular myocytes displayed a 90% (p < 0.001) decline in MHC-alpha mRNA levels and over a twofold (p < 0.01) increase in MHC-beta transcripts when compared to sham-operated controls. Consistent with these changes we also observed a substantial decline in the ratio of MHC-alpha to MHC-beta protein expression. A reversal in myosin heavy chain composition was achieved following testosterone replacement. These studies provide the first direct evidence that testosterone replacement in gonadectomized animals enhances contractility via transcriptional and translational control of myosin heavy chain composition in isolated rat ventricular myocytes. The influence of testosterone on MHC composition in males may underlie some of the observed sex differences in cardiac function.


Subject(s)
Myocytes, Cardiac/chemistry , Myosin Heavy Chains/analysis , Orchiectomy , Testosterone/physiology , Animals , Male , Myocardial Contraction , Myosin Heavy Chains/genetics , RNA, Messenger/analysis , Rats , Rats, Sprague-Dawley , Testosterone/administration & dosage
6.
Am J Physiol Endocrinol Metab ; 285(3): E449-53, 2003 Sep.
Article in English | MEDLINE | ID: mdl-12684218

ABSTRACT

Sex-related differences in cardiac function have been well documented. The extent to which sex hormones are responsible for these differences is unclear. The current study was designed to determine whether castration and androgen replacement resulted in changes in functional expression of genes encoding the L-type calcium channel and Na/Ca exchanger in isolated rat ventricular myocytes. Sixteen weeks of castration produced a 50% decline in dihydropyridine receptor expression levels and a 16% (P < 0.05) increase in time to peak shortening. Furthermore, cardiac myocytes isolated from castrated animals also displayed an 18% (P < 0.001) increase in time to relengthening and an 80% decrease in Na/Ca exchanger gene expression when compared with intact controls. Testosterone treatment of castrated animals completely reversed these effects. These results provide the first evidence that androgens regulate functional expression of the L-type calcium channel and the Na/Ca exchanger in isolated rat ventricular myocytes and thus may play a role in modulating cardiac performance in males and thereby contribute to the observed gender differences in cardiac function.


Subject(s)
Myocardial Contraction/physiology , Myocytes, Cardiac/physiology , Orchiectomy , Animals , Calcium Channels, L-Type/genetics , Gene Expression , Gonadal Steroid Hormones/pharmacology , Gonadal Steroid Hormones/physiology , Heart Ventricles/cytology , In Vitro Techniques , Male , Myocardial Contraction/drug effects , RNA, Messenger/analysis , Rats , Rats, Sprague-Dawley , Sodium-Calcium Exchanger/genetics , Testosterone/pharmacology , Testosterone/physiology
7.
Exp Biol Med (Maywood) ; 227(1): 32-5, 2002 Jan.
Article in English | MEDLINE | ID: mdl-11788781

ABSTRACT

Studies were carried out primarily to assess the role of insulin in regulating iodide uptake in the mammary gland. Using cultured mammary gland explants from virgin and pregnant mice (12-14 days into gestation), insulin (1 microg/ml) was shown to stimulate iodide uptake after a 2-day exposure period. The effect of insulin was manifested by itself, as well as in the presence of cortisol and prolactin. Optimal iodide uptake was observed when tissues were treated with all three lactogenic hormones (insulin, cortisol, and prolactin). In a time-course experiment, the effect of insulin alone was initially observed after a 10-hr treatment; the effect was maintained for 30 hr. In dose-response studies, 1 ng/ml insulin elicited a significant effect after 24 hr in culture; a maximal effect was achieved with 50-100 ng/ml insulin. The optimal cortisol concentration for a maximum stimulation of iodide uptake was 10(-7)M. In a quantitative Western blot analysis employing an antibody to the sodium-iodide symporter, insulin stimulated an upregulation of the transporter protein after a 4-, 8-, or 20-hr treatment with insulin. Perchlorate and thiocyanate abolished the insulin effect on iodide uptake, further suggesting that the insulin response occurs via a stimulation of the sodium-iodide symporter. Clearly, insulin is an important and essential hormone in the lactogenic hormone complex for regulating iodide uptake in the mammary gland, but maximal expression of iodide uptake is only expressed when all three lactogenic hormones are present.


Subject(s)
Hypoglycemic Agents/pharmacology , Insulin/pharmacology , Iodides/metabolism , Mammary Glands, Animal/metabolism , Animals , Anti-Inflammatory Agents/pharmacology , Culture Techniques , Dose-Response Relationship, Drug , Female , Hydrocortisone/pharmacology , Mice , Pregnancy , Prolactin/pharmacology , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...